P65 mediated UBR4 in exosomes derived from menstrual blood stromal cells to reduce endometrial fibrosis by regulating YAP Ubiquitination.
Endometrial fibrosis
Exosomes
MenSCs
Ubiquitination
ubr4
Journal
Journal of nanobiotechnology
ISSN: 1477-3155
Titre abrégé: J Nanobiotechnology
Pays: England
ID NLM: 101152208
Informations de publication
Date de publication:
29 Aug 2023
29 Aug 2023
Historique:
received:
03
07
2023
accepted:
18
08
2023
medline:
31
8
2023
pubmed:
30
8
2023
entrez:
29
8
2023
Statut:
epublish
Résumé
Intrauterine adhesion (IUA) is a recurrent and refractory reproductive dysfunction disorder for which menstrual blood-derived stromal cells (MenSCs) might be a promising intervention. We reported that administration of MenSCs-derived exosomes (MenSCs-EXO) could achieve similar therapeutic effects to MenSCs transplantation, including alleviating endometrial fibrosis and improving fertility in IUA rats. The mass spectrometry sequencing result suggested that UBR4, a member of the proteasome family, was abundantly enriched in MenSCs-EXO. This study aimed to investigate the key role of UBR4 in MenSCs-EXO for the treatment of IUA and the specific molecular mechanism. UBR4 was lowly expressed in the endometrial stromal cells (EndoSCs) of IUA patients. MenSCs-EXO treatment could restore the morphology of IUA endometrium, reduce the extent of fibrosis, and promote endometrial and vascular proliferation. Knockdown of UBR4 in MenSCs did not affect the characteristics of exosomes but attenuated the therapeutic effect of exosomes. UBR4 in MenSCs-EXO could alleviate endometrial fibrosis by boosting YAP ubiquitination degradation and promoting YAP nuclear-cytoplasmic translocation. Moreover, P65 could bind to the UBR4 promoter region to transcriptionally promote the expression level of UBR4 in MenSCs. Our study clarified that MenSCs-EXO ameliorated endometrial fibrosis in IUA primarily by affecting YAP activity mediated through UBR4, while inflammatory signaling P65 may affect UBR4 expression in MenSCs to enhance MenSCs-EXO therapeutic effects. This revealed a novel mechanism for the treatment of IUA with MenSCs-EXO, proposing a potential option for the clinical treatment of endometrial injury.
Sections du résumé
BACKGROUND
BACKGROUND
Intrauterine adhesion (IUA) is a recurrent and refractory reproductive dysfunction disorder for which menstrual blood-derived stromal cells (MenSCs) might be a promising intervention. We reported that administration of MenSCs-derived exosomes (MenSCs-EXO) could achieve similar therapeutic effects to MenSCs transplantation, including alleviating endometrial fibrosis and improving fertility in IUA rats. The mass spectrometry sequencing result suggested that UBR4, a member of the proteasome family, was abundantly enriched in MenSCs-EXO. This study aimed to investigate the key role of UBR4 in MenSCs-EXO for the treatment of IUA and the specific molecular mechanism.
RESULTS
RESULTS
UBR4 was lowly expressed in the endometrial stromal cells (EndoSCs) of IUA patients. MenSCs-EXO treatment could restore the morphology of IUA endometrium, reduce the extent of fibrosis, and promote endometrial and vascular proliferation. Knockdown of UBR4 in MenSCs did not affect the characteristics of exosomes but attenuated the therapeutic effect of exosomes. UBR4 in MenSCs-EXO could alleviate endometrial fibrosis by boosting YAP ubiquitination degradation and promoting YAP nuclear-cytoplasmic translocation. Moreover, P65 could bind to the UBR4 promoter region to transcriptionally promote the expression level of UBR4 in MenSCs.
CONCLUSION
CONCLUSIONS
Our study clarified that MenSCs-EXO ameliorated endometrial fibrosis in IUA primarily by affecting YAP activity mediated through UBR4, while inflammatory signaling P65 may affect UBR4 expression in MenSCs to enhance MenSCs-EXO therapeutic effects. This revealed a novel mechanism for the treatment of IUA with MenSCs-EXO, proposing a potential option for the clinical treatment of endometrial injury.
Identifiants
pubmed: 37644565
doi: 10.1186/s12951-023-02070-3
pii: 10.1186/s12951-023-02070-3
pmc: PMC10463480
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
305Subventions
Organisme : the Natural Science Foundation Program of Liaoning Province
ID : 2022-YGJC-72
Organisme : the National Nature Science Foundation of China
ID : 82071601
Organisme : Science and technology funding projects to support high-quality development of China Medical University
ID : 2022JH2/20200052
Organisme : the Major Special Construction Plan for Discipline Construction Project of China Medical University
ID : 3110118033
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Foix A, Bruno RO, Davison T, Lema B. The pathology of postcurettage intrauterine adhesions. Am J Obstet Gynecol. 1966;96(7):1027–33.
pubmed: 5928449
Schenker JG. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol. 1996;65(1):109–13.
pubmed: 8706941
Myers EM, Hurst BS. Comprehensive management of severe Asherman syndrome and amenorrhea. Fertil Steril. 2012;97(1):160–4.
pubmed: 22100167
Santamaria X, Cabanillas S, Cervelló I, et al. Autologous cell therapy with CD133 + bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016;31(5):1087–96.
pubmed: 27005892
Zhao G, Cao Y, Zhu X, et al. Transplantation of collagen scaffold with autologous bone marrow mononuclear cells promotes functional endometrium reconstruction via downregulating ∆Np63 expression in Asherman’s syndrome. Sci China Life Sci. 2017;60(4):404–16.
pubmed: 27921235
Cao Y, Sun H, Zhu H, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9(1):192.
pubmed: 29996892
pmcid: 6042450
Tan J, Li P, Wang Q, et al. Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome. Hum Reprod. 2016;31(12):2723–9.
pubmed: 27664218
Gao M, Yu Z, Yao D, Qian Y, Wang Q, Jia R. Mesenchymal stem cells therapy: a promising method for the treatment of uterine scars and premature ovarian failure. Tissue Cell. 2022;74:101676.
pubmed: 34798583
Rahmati S, Shojaei F, Shojaeian A, Rezakhani L, Dehkordi MB. An overview of current knowledge in biological functions and potential theragnostic applications of exosomes. Chem Phys Lipids. 2020;226:104836.
pubmed: 31678051
Nazdikbin Yamchi N, Ahmadian S, Mobarak H, et al. Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-β/Smads signaling pathway. J Ovarian Res. 2023;16(1):118.
pubmed: 37370156
pmcid: 10294370
Park HS, Cetin E, Siblini H et al. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles to treat PCOS. Int J Mol Sci. 2023. 24(13).
Zhang H, Fang Y, Gao Y, et al. Brown adipose tissue-derived exosomes delay fertility decline in aging mice. Front Endocrinol (Lausanne). 2023;14:1180104.
pubmed: 37305038
Rahmati S, Khazaei M, Nadi A, Alizadeh M, Rezakhani L. Exosome-loaded scaffolds for regenerative medicine in hard tissues. Tissue Cell. 2023;82:102102.
pubmed: 37178527
Liu Y, Zhang S, Xue Z, et al. Bone mesenchymal stem cells-derived mir-223-3p-containing exosomes ameliorate lipopolysaccharide-induced acute uterine injury via interacting with endothelial progenitor cells. Bioengineered. 2021;12(2):10654–65.
pubmed: 34738867
pmcid: 8810142
Tan Q, Xia D, Ying X. miR-29a in Exosomes from Bone Marrow mesenchymal stem cells inhibit fibrosis during endometrial repair of Intrauterine Adhesion. Int J Stem Cells. 2020;13(3):414–23.
pubmed: 33250449
pmcid: 7691861
Zhao S, Qi W, Zheng J, et al. Exosomes derived from adipose mesenchymal stem cells restore functional endometrium in a rat model of Intrauterine Adhesions. Reprod Sci. 2020;27(6):1266–75.
pubmed: 31933162
Zhang S, Chang Q, Li P, et al. Concentrated small extracellular vesicles from menstrual blood-derived stromal cells improve intrauterine adhesion, a pre-clinical study in a rat model. Nanoscale. 2021;13(15):7334–47.
pubmed: 33889891
Zhang S, Li P, Yuan Z, Tan J. Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion. Stem Cell Res Ther. 2019;10(1):61.
pubmed: 30770774
pmcid: 6377773
Moya IM, Halder G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019;20(4):211–26.
pubmed: 30546055
Kim CL, Choi SH, Mo JS. Role of the Hippo Pathway in Fibrosis and Cancer. Cells. 2019. 8(5).
Yu SM, Bonventre JV. Acute kidney injury and maladaptive tubular repair leading to renal fibrosis. Curr Opin Nephrol Hypertens. 2020;29(3):310–8.
pubmed: 32205583
pmcid: 7363449
Chen YH, Xu YC, Lin TT, et al. Exosomal MiR-381 from M2-polarized macrophages attenuates urethral fibroblasts activation through YAP/GLS1-regulated glutaminolysis. Inflamm Res. 2023;72(7):1359–73.
pubmed: 37340070
Zhao Y, Wang H, He T, Ma B, Chen G, Tzeng C. Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals. J Cell Commun Signal. 2023.
Salamonsen LA. Tissue injury and repair in the female human reproductive tract. Reproduction. 2003;125(3):301–11.
pubmed: 12611594
Zhu H, Pan Y, Jiang Y, Li J, Zhang Y, Zhang S. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells. Hum Reprod. 2019;34(4):635–45.
pubmed: 30715393
Inui N, Sakai S, Kitagawa M. Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways related to TGF-β and the ubiquitin-proteasome pathway. Int J Mol Sci. 2021. 22(11).
Akhouri V, Majumder S, Gaikwad AB. The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease. Life Sci. 2023;321:121643.
pubmed: 36997061
Ji C, Zhang J, Zhu Y, et al. Exosomes derived from hucMSC attenuate renal fibrosis through CK1δ/β-TRCP-mediated YAP degradation. Cell Death Dis. 2020;11(5):327.
pubmed: 32382019
pmcid: 7205986
Kim ST, Lee YJ, Tasaki T, et al. The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins. PLoS ONE. 2018;13(8):e0202260.
pubmed: 30157281
pmcid: 6114712
Kim ST, Lee YJ, Tasaki T et al. The N-recognin UBR4 of the N-end rule pathway is targeted to and required for the biogenesis of the early endosome. J Cell Sci. 2018. 131(17).
Hunt LC, Schadeberg B, Stover J, et al. Antagonistic control of myofiber size and muscle protein quality control by the ubiquitin ligase UBR4 during aging. Nat Commun. 2021;12(1):1418.
pubmed: 33658508
pmcid: 7930053
Sakai H, Ohuchida K, Mizumoto K, et al. Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer. Ann Surg Oncol. 2011;18(7):2057–65.
pubmed: 21347795
pmcid: 3115059
Kondylis V, Kumari S, Vlantis K, Pasparakis M. The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol Rev. 2017;277(1):113–27.
pubmed: 28462531
Chen M, Reed RR, Lane AP. Acute inflammation regulates neuroregeneration through the NF-κB pathway in olfactory epithelium. Proc Natl Acad Sci U S A. 2017;114(30):8089–94.
pubmed: 28696292
pmcid: 5544262
González-Ramos R, Rocco J, Rojas C, et al. Physiologic activation of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients. Fertil Steril. 2012;97(3):645–51.
pubmed: 22196717
Zhang Y, Cao C, Du S, et al. Estrogen regulates endoplasmic reticulum stress-mediated apoptosis by ERK-p65 pathway to promote endometrial angiogenesis. Reprod Sci. 2021;28(4):1216–26.
pubmed: 33409875
Yamashita M, Passegué E. TNF-α coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell. 2019;25(3):357–372e7.
pubmed: 31230859
pmcid: 6733032
Morreale FE, Walden H. Types of Ubiquitin Ligases. Cell. 2016;165(1):248–248e1.
pubmed: 27015313
Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem. 2009;78:477–513.
pubmed: 19489727
pmcid: 3431160
Fukasawa H, Yamamoto T, Togawa A, et al. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A. 2004;101(23):8687–92.
pubmed: 15173588
pmcid: 423256
Chung S, Nakashima M, Zembutsu H, Nakamura Y. Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(8):563–73.
pubmed: 21986318
pmcid: 3313695
Moon B, Chang S. Exosome as a delivery vehicle for Cancer Therapy. Cells. 2022. 11(3).
Yao Y, Chen R, Wang G, Zhang Y, Liu F. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium. Stem Cell Res Ther. 2019;10(1):225.
pubmed: 31358049
pmcid: 6664513
Rape M. Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol. 2018;19(1):59–70.
pubmed: 28928488
Liu Y, Xu C, Li J, et al. YAP promotes AP-1 expression in tubular epithelial cells in the kidney. Am J Physiol Renal Physiol. 2023;324(6):F581–9.
pubmed: 37141146
Cheng F, Yang F, Wang Y, Zhou J, Qian H, Yan Y. Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway. J Nanobiotechnol. 2023;21(1):195.
Lu ZN, Niu WX, Zhang N, et al. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacol Sin. 2021;42(11):1808–20.
pubmed: 34465912
pmcid: 8563954
Yi C, Shen Z, Stemmer-Rachamimov A, et al. The p130 isoform of angiomotin is required for yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal. 2013;6(291):ra77.
pubmed: 24003254
pmcid: 4175526
Xue X, Chen Q, Zhao G, Zhao JY, Duan Z, Zheng PS. The overexpression of TGF-β and CCN2 in Intrauterine Adhesions involves the NF-κB signaling pathway. PLoS ONE. 2015;10(12):e0146159.
pubmed: 26719893
pmcid: 4697802
Wu J, Jin L, Zhang Y, et al. LncRNA HOTAIR promotes endometrial fibrosis by activating TGF-β1/Smad pathway. Acta Biochim Biophys Sin (Shanghai). 2020;52(12):1337–47.
pubmed: 33313721
Zhang Z, Li S, Deng J, et al. Aspirin inhibits endometrial fibrosis by suppressing the TGF–β1–Smad2/Smad3 pathway in intrauterine adhesions. Int J Mol Med. 2020;45(5):1351–60.
pubmed: 32323728
pmcid: 7138280
Zhang X, Zhang S, Qi J, et al. PDGFBB improved the biological function of menstrual blood-derived stromal cells and the anti-fibrotic properties of exosomes. Stem Cell Res Ther. 2023;14(1):113.
pubmed: 37118830
pmcid: 10148410
Asadi A, Goudarzi F, Ghanadian M, Mohammadalipour A. Evaluation of the osteogenic effect of apigenin on human mesenchymal stem cells by inhibiting inflammation through modulation of NF-κB/IκBα. Res Pharm Sci. 2022;17(6):697–706.
pubmed: 36704428
pmcid: 9872176
Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M. The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacology. 2021;29(1):91–100.
pubmed: 33159646
Wang Y, Liu Y, Zhang M, et al. LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation. Stem Cell Res Ther. 2018;9(1):65.
pubmed: 29523191
pmcid: 5845373
Chen Y, Pethö A, Ganapathy A, George A. DPP promotes odontogenic differentiation of DPSCs through NF-κB signaling. Sci Rep. 2021;11(1):22076.
pubmed: 34764323
pmcid: 8586344